Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels

Neil H. Riordan, Maria Luisa Hincapié, Isabela Morales, Giselle Fernandez, Nicole Allen, Cindy Leu, Marialaura Madrigal, Jorge Paz Rodriguez, Nelson Navarro First published: 11 June 2019 https://doi.org/10.1002/sctm.19-0010 Data Availability Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request. Abstract Individuals with autism spectrum disorder (ASD) [...]

The Effect of Umbilical Cord-derived Mesenchymal Stem Cell Transplantation in a Patient with Cerebral Palsy: A Case Report.

Okur SÇ1, Erdoğan S2, Demir CS3, Günel G3, Karaöz E2,3,4. Author Information: 1 Department of Physical Therapy and Rehab, Health Science University, Bakirköy Dr Sadi Konuk Training and Research Hospital, İstanbul, Turkey. 2 Department of Histology and Embryology, İstinye University, Faculty of Medicine, İstanbul, Turkey. 3 Center for Stem Cell and Tissue Engineering Research and Practice, İstinye University, İstanbul, [...]

VIDEO: Neil Riordan, PA, PhD discusses Stem Cells: Their Role in Aging and in the Treatment of Chronic Diseases

At our May 4th 2019 event in Southlake, Texas, Dr. Riordan discusses stem cell therapy at the Stem Cell Institute in Panama City, Panama. He mentions the two main types of adult stem cells but his talk focuses on mesenchymal stem cells including their sources and functions. Then he goes on to [...]

Multiple Sclerosis News Today: Stem Cell Institute MS Trial is #4 in Top 10 MS Stories of 2018

Congratulations to Dr. Riordan and everyone at Stem Cell Institute and Medistem Labs in Panama! Multiple Sclerosis News Today published its Top 10 Multiple Sclerosis Stories of 2018 and named Stem Cell Institute's MS clinical trial its #4 top MS story of 2018. The name of the article that reached #4 is “Treatment [...]

Regenerative Medicine Center Opens at Southwest College of Naturopathic Medicine and Health Sciences

The Neil Riordan Center for Regenerative Medicine Focuses on Non-Opioid Treatments of Pain (Tempe, Arizona, October 2, 2018)--Southwest College of Naturopathic Medicine & Health Sciences team will cut the ribbon for the opening of the new Neil Riordan Center for Regenerative Medicine on November 15 at 4:00 p.m. This affiliation between SCNM and [...]

Multiple Sclerosis News Today Covers Stem Cell Institute Clinical Trial for MS

Stem cells being prepared for treatment. Multiple Sclerosis News Today has published an article entitled "Treatment with Umbilical Cord Stem Cells Safe with Sustained Benefits for MS, Trial Shows". This article can be read in its entirely at MultipleSclerosisNewsToday.com.The name of the study, which is published in the Journal of Translational Medicine, is “Clinical [...]

Applied Stem Cell Therapy Expert, Neil Riordan, PhD, Authors “Cell Therapy for Liver Failure: A New Horizon” in Contemporary Liver Transplantation Medical Reference

DALLAS-FORT WORTH, TEXAS (PRWEB) NOVEMBER 08, 2016 (Original Press Release on PRWeb) Neil Riordan, PhD A new chapter by renowned applied stem cell therapy expert, Neil Riordan, PhD of the Riordan-McKenna Institute in Southlake, Texas; Medistem Labs Panama, and the Stem Cell Institute in Panama City, Panama, entitled, “Cell Therapy for Liver Failure: A [...]

Umbilical Cord Tissue Mesenchymal Stem Cells Best For Clinical Applications

A recent study concluded that umbilical cord tissue is the best source for clinically utilizable mesenchymal stem cells. Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton’s Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells. Arjunan Subramanian, Chui-Yee Fong, Arijit Biswas, Ariff Bongso [...]

US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US

(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application [...]

First Duchenne’s Muscular Dystrophy Patient To Receive Umbilical Cord Stem Cell Therapy In US Turns 30

The first patient with Duchenne Muscular Dystrophy to be granted FDA approval for allogeneic adult stem cell therapy in the United States turned 30 this year, well surpassing his original life expectancy and paving the way for future patients, according to non-profit organization Coming Together For A Cure. Ryan Benton WICHITA, KANSAS (PRWEB) MAY [...]